Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-17 Purchase | 2026-06-22 07:12 am | Nasus Pharma Ltd | NSRX | Teleman Dan Benjamin Chief Executive Officer | 6,550 | $3.1 | $20,305 | 163,541 (Direct) | View |
| 2026-04-22 Purchase | 2026-04-22 9:44 pm | Nasus Pharma Ltd | NSRX | Teleman Dan Benjamin Chief Executive Officer | 2,900 | $3.76 | $10,904 | 156,991 (Direct) | View |
| 2026-03-31 Purchase | 2026-04-01 07:31 am | Nasus Pharma Ltd | NSRX | Teleman Dan Benjamin Chief Executive Officer | 15,000 | $2.04 | $30,600 | 21,246 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-03-27 9:37 pm | 2027-02-27 2035-11-20 | Nasus Pharma Ltd | NSRX | Rubin Eyal Chief Financial Officer | 0 | $0 | 126,197 (Direct) | View |
Ownership | 2026-03-27 8:56 pm | 2026-03-11 2035-12-11 | Nasus Pharma Ltd | NSRX | Silberman David Director | 0 | $0 | 10,000 (Direct) | View |
Ownership | 2026-03-27 8:56 pm | N/A N/A | Nasus Pharma Ltd | NSRX | Teleman Dan Benjamin Chief Executive Officer | 0 | $0 | 325,102 (Direct) | View |
Ownership | 2026-03-27 8:56 pm | 2026-03-11 2035-12-11 | Nasus Pharma Ltd | NSRX | Shacham Sharon Director | 0 | $0 | 10,000 (Direct) | View |
Ownership | 2026-03-27 8:56 pm | N/A N/A | Nasus Pharma Ltd | NSRX | Gilboa Udi Founder & Executive Chairman | 0 | $0 | 1,942,446 (Direct) | View |
Ownership | 2026-03-27 8:56 pm | N/A N/A | Nasus Pharma Ltd | NSRX | Hershman Ronnie Director | 0 | $0 | 1,419,450 (Indirect) | View |
Ownership | 2026-03-27 8:56 pm | N/A N/A | Nasus Pharma Ltd | NSRX | Megiddo Dalia Chief Development Officer | 0 | $0 | 1,894,068 (Direct) | View |
Ownership | 2026-03-27 8:56 pm | 2026-03-11 2035-12-11 | Nasus Pharma Ltd | NSRX | Israel Isaac Director | 0 | $0 | 10,000 (Direct) | View |